What do you actually need to become a CRA?
A life-science degree, a real grasp of ICH-GCP, and some clinical exposure. The title on your last contract matters far less than whether you can show monitoring competence and therapeutic-area fit. Most people get in through one of three doors: an in-house or centralised CRA role, a study-coordinator or CTA role translated into monitoring language, or a graduate CRA programme at a large CRO. This is a guide to which door fits you, and how to walk through it.
The Clinical Research Associate role is one of the most common ways into pharma, and one of the most misunderstood from the outside. People assume you need years of on-site monitoring before anyone will look at you. You do not. But you do need to present the experience you have in the language a clinical hiring manager reads in.
I spent 13 years recruiting inside Bayer AG and two global Top 5 CROs, ICON and Syneos Health, where staffing clinical operations was a large part of the job. Here is what actually gets someone hired as a CRA in Germany, Austria and Switzerland.
The baseline: degree, GCP, and some clinical contact
Almost every CRA posting asks for a degree in a life science, sometimes nursing or pharmacy, and knowledge of ICH-GCP. That is the floor, not the differentiator. What separates candidates is evidence that you understand how a trial runs on the ground: source data verification, protocol deviations, site relationships, and the discipline of keeping documentation audit-ready. If you have touched any of that, even adjacent to it, you have more to work with than you think.
Three realistic entry routes
In-house or centralised CRA. Many CROs and sponsors hire in-house CRAs who monitor remotely before moving to on-site work. It is the most common first rung and the easiest to reach from a graduate or coordinator background.
From a site or coordinator role. Study coordinators, CTAs and study nurses already understand GCP, deviations and site logistics from the other side of the table. That experience is gold, but only if your CV translates it into monitoring terms rather than site-operations terms. This is where most transitions stall, and where a rewrite pays for itself.
Graduate CRA programme. The large CROs run structured entry programmes. They are competitive and heavily filtered by applicant tracking systems, so the CV has to parse cleanly and speak the language before a human ever reads it.
What recruiters and the ATS actually check
When a clinical CV crossed my desk, I was scanning for specifics, not adjectives. Which monitoring visit types have you run, site initiation, interim, close-out? Which phases, I through IV? Which therapeutic areas? Which systems, CTMS and EDC platforms such as Medidata Rave or Veeva Vault? And crucially, the numbers, how many sites and visits. A CV that says "responsible for clinical monitoring" gives a screening system nothing to match and a recruiter nothing to trust.
The applicant tracking systems used across DACH pharma are not the villains LinkedIn makes them out to be, but they do filter on the terms recruiters search for. If your document does not contain the vocabulary of monitoring and GCP, you are invisible at the exact moment it matters.
The DACH-specific reality
Two things trip up otherwise strong candidates here. The first is language: many CRO roles run in English, but German widens your options considerably for site-facing work with German-speaking investigators, and Switzerland and Austria have their own conventions. The second is the choice between a sponsor and a CRO, which shapes travel, autonomy, pay and progression in ways a job advert rarely spells out. Being deliberate about both is the difference between a focused search and a scattered one.
For a full breakdown of the role, the employers hiring across DACH, and how the sponsor-versus-CRO decision plays out, see the dedicated guide: Clinical Research Associate (CRA) & Clinical Operations careers in DACH pharma.
A word on salary
People always want a number. I will not invent one, because a credible CRA salary in DACH depends on seniority, whether you sit with a CRO or a sponsor, home-based versus office, region and therapeutic area, and any figure I quote without those variables would be misleading. What I can tell you is that positioning yourself for the sponsor path, or for a senior CRA move, changes the range more than any negotiation tactic. Get the target right first.
The move that actually works
The transition into a CRA role is common and very doable. It rarely happens by applying cold through a portal. It works when your transferable clinical experience is translated into monitoring language, your CV passes the ATS, and you are put in front of the CROs and sponsors that hire at entry level, including the roles that never reach the public job boards. That translation and targeting is the core of what I do, from the recruiting side.
© 13 July 2026 Andreas Schulz. All rights reserved.
Targeting a CRA move in DACH?
Book a free getting-to-know call. I will tell you honestly where your clinical-operations search stands, which door fits your background, and whether a structured approach would shorten it.
Book a Free Getting to Know Call